Vincerx Pharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
VINC Nasdaq 2830 vincerx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vincerx Pharma, Inc.

Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI - Mar 18th, 2025 1:39 pm
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - Mar 18th, 2025 12:52 pm
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - Feb 28th, 2025 9:05 pm
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 - Jan 29th, 2025 1:00 pm
Vincerx Pharma, Inc. Announces Reverse Stock Split - Jan 23rd, 2025 9:05 pm
Vincerx Pharma to Be Acquired by Oqory; Vincerx to Lose Jobs, Including Executives - Dec 27th, 2024 10:11 pm
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Dec 27th, 2024 9:05 pm
Vincerx Pharma announces workforce reduction of 55%, cost-control measures - Dec 5th, 2024 11:50 am
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - Dec 4th, 2024 11:45 am
Vincerx Pharma Reports Third Quarter 2024 Financial Results - Nov 12th, 2024 2:00 pm
What Makes Vincerx Pharma (VINC) a New Buy Stock - Oct 10th, 2024 4:00 pm
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates - Oct 7th, 2024 8:05 pm
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky - Aug 21st, 2024 10:55 am
Vincerx Pharma Reports Second Quarter 2024 Financial Results - Aug 8th, 2024 8:30 pm
Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade - Jun 27th, 2024 4:00 pm
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - May 14th, 2024 8:15 pm
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - Apr 26th, 2024 4:27 am
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - Apr 25th, 2024 8:01 pm
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study - Apr 9th, 2024 5:34 pm
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday? - Apr 9th, 2024 4:29 pm